Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients.
about
Current research on pharmacologic and regenerative therapies for osteoarthritisStrategies to Maximize the Potential of Marine Biomaterials as a Platform for Cell TherapyCartilage regenerationProgress in intra-articular therapyGene therapy approaches to regenerating the musculoskeletal systemImmunogenicity and immunomodulatory effects of the human chondrocytes, hChonJ.Unlike bone, cartilage regeneration remains elusive.Type II collagen and glycosaminoglycan expression induction in primary human chondrocyte by TGF-β1.A Road Map to Commercialization of Cartilage Therapy in the United States of America.Knee Articular Cartilage Repair and Restoration Techniques: A Review of the LiteratureArthritis gene therapy and its tortuous path into the clinic.Novel approaches for treating musculoskeletal diseases: molecular orthopedics and systems medicine.Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytesAdvances and challenges in gene-based approaches for osteoarthritis.New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?Using genes to facilitate the endogenous repair and regeneration of orthopaedic tissuesUse of tissue engineering strategies to repair joint tissues in osteoarthritis: viral gene transfer approaches.Tissue-engineering strategies to repair joint tissue in osteoarthritis: nonviral gene-transfer approaches.Genetically modified chondrocytes expressing TGF-β1: a revolutionary treatment for articular cartilage damage?Cartilage tissue engineering: recent advances and perspectives from gene regulation/therapy.Efficient, Low-Cost Nucleofection of Passaged Chondrocytes.Orthopedic cellular therapy: An overview with focus on clinical trials.Strategies for improving the repair of focal cartilage defects.Gene therapy for chondral and osteochondral regeneration: is the future now?Gene therapy for human osteoarthritis: principles and clinical translation.BMP-2 gene activated muscle tissue fragments for osteochondral defect regeneration in the rabbit knee.Intra-articular therapies for osteoarthritis.An update on the up and coming therapies to treat osteoarthritis, a multifaceted disease.TGF-β1 conjugated chitosan collagen hydrogels induce chondrogenic differentiation of human synovium-derived stem cells.rAAV-mediated overexpression of TGF-β stably restructures human osteoarthritic articular cartilage in situ.Advances in regenerative orthopedics.Structural effects of intra-articular TGF-β1 in moderate to advanced knee osteoarthritis: MRI-based assessment in a randomized controlled trial.A Magnetically Actuated Microscaffold Containing Mesenchymal Stem Cells for Articular Cartilage Repair.Use of recombinant human stromal cell-derived factor 1α-loaded fibrin/hyaluronic acid hydrogel networks to achieve functional repair of full-thickness bovine articular cartilage via homing of chondrogenic progenitor cells.Cell Culture MethodsTrends in clinical trials for articular cartilage repair by cell therapy
P2860
Q26766598-BFFA39E2-65AF-4881-86E2-51DAD72E4AF8Q26773060-22EFB484-EAC5-4749-BAF3-FF7761E26192Q26830668-D01BCD37-D892-4E99-92A6-5B367908D670Q26851258-1C374070-8EED-48C7-8DB0-322E5B117068Q28083399-6EAE06B5-57B4-4F8D-8467-D05414CC8F4CQ33706923-671DDCE4-1948-482A-9F40-29C2ABB8A1C4Q35083189-B82F4F43-3B7A-4C17-8445-A1B094684DC8Q35658985-4BB079D7-D080-40AA-AF85-F5D4B06F544FQ36579908-C47CC728-709C-4B92-A7B0-5177445D6E29Q36682485-9FC21EBB-9017-44DF-9735-D8F1DC2711B0Q36698181-AEB8C6C2-ECF8-40AA-9BE3-34ACE7023A4CQ36876937-53DF294D-8B00-479D-8B08-E66BFA7B2901Q37225109-C216017F-EB94-4B88-AE88-54EEA9DA8885Q38134331-660F46AE-D8D6-43E7-911D-B3ACC01F8DADQ38138598-29E9027A-EC09-4D5D-BE24-C4DF38DC62B0Q38231254-ADA269FD-28D9-4EA3-9DA5-183D8CC50272Q38245620-92FF212E-F75D-4CBC-9291-A545462676DDQ38245621-19CC5E1E-AC4F-4C95-87AB-D5D4A4CEADD4Q38341891-26324741-97E1-42E0-A02C-9C7CE333C90CQ38345989-34C734E1-1CDE-4CB4-B5D8-D9C48CDBD421Q38362292-30C2DC66-3124-4BF6-A1BB-C7F4D1E4E12EQ38420247-E7C6EE80-4E63-4805-9C0B-AECF49FE47FEQ38588044-40ABD06A-9138-43A8-97A0-19A8A304B8F1Q38634077-6C065350-4DD3-4F1B-8375-44BF0967C8E8Q38642703-FA301DB7-35AE-4614-BDB3-1282AAFD23A3Q38660922-FDACDEEE-8DF4-4035-A929-3A68BE99E9B2Q38823835-62BBBDB4-1FD6-4E8A-8E96-6223D0D38446Q38871811-B892D178-4728-4EF7-93A4-D3BC0701768CQ41829310-714FDE2C-C0E6-4A98-A429-822F352E9989Q42269793-DBF1CCC3-B9A1-449B-AD4B-F6571CDCD5ABQ42968649-FBA39128-C226-4161-9BE4-33A6F84FEEACQ47606881-23932371-AF5D-4B08-B999-F367243C9787Q50885015-ADA3826D-B96E-447B-9A02-FC8ECE685B8AQ53634977-6145F26B-38B8-4549-A253-30ABEDEB4EC3Q57170631-D97CE600-AC51-4ADB-B095-650ACADE5EA0Q57816005-4C708BAB-9F3B-476F-B3E0-BC23E1CAAFA8
P2860
Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Initial phase I safety of retr ...... generative arthritis patients.
@en
Initial phase I safety of retr ...... generative arthritis patients.
@nl
type
label
Initial phase I safety of retr ...... generative arthritis patients.
@en
Initial phase I safety of retr ...... generative arthritis patients.
@nl
prefLabel
Initial phase I safety of retr ...... generative arthritis patients.
@en
Initial phase I safety of retr ...... generative arthritis patients.
@nl
P2093
P2860
P1433
P1476
Initial phase I safety of retr ...... generative arthritis patients.
@en
P2093
Kwan Hee Lee
Kyoung Baek Choi
Moon Jong Noh
P2860
P304
P356
10.3109/14653249.2011.629645
P50
P577
2012-02-01T00:00:00Z